Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Powers

Showing results (221-230 of 255) with videos related to

Pageof 26
Sort By:
The Journal of Organic Chemistry|August 19, 2007
An efficient and scalable one-pot double Michael addition-Dieckmann condensation for the synthesis of 4,4-disubstituted cyclohexane beta-keto estersMichael R DeGraffenreid, Sarah Bennett, Sebastien Caille, et al.
Clinical Pharmacology and Therapeutics|April 1, 2011
Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical doseD J Dairaghi, P Zhang, Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)Daqing Sun, Zhulun Wang, Yongmei Di, et al.
Biological Psychology|May 30, 2013
White matter microstructure is associated with cognitive control in childrenLaura Chaddock-Heyman, Kirk I Erickson, Michelle W Voss, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.
Journal of Medicinal Chemistry|February 3, 2006
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymeraseJay P Powers, Derek E Piper, Yang Li, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitorsYosup Rew, Dustin L McMinn, Zhulun Wang, et al.
Proceedings. Biological Sciences|June 15, 2012
Historical ecology with real numbers: past and present extent and biomass of an imperilled estuarine habitatPhiline S E Zu Ermgassen, Mark D Spalding, Brady Blake, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1Hua Tu, Jay P Powers, Jinsong Liu, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Pageof 26

Showing results (221-230 of 255) with videos related to

Sort By:
Pageof 26
The Journal of Organic Chemistry|August 19, 2007
An efficient and scalable one-pot double Michael addition-Dieckmann condensation for the synthesis of 4,4-disubstituted cyclohexane beta-keto estersMichael R DeGraffenreid, Sarah Bennett, Sebastien Caille, et al.
Clinical Pharmacology and Therapeutics|April 1, 2011
Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical doseD J Dairaghi, P Zhang, Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 31, 2008
Discovery and initial SAR of arylsulfonylpiperazine inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1)Daqing Sun, Zhulun Wang, Yongmei Di, et al.
Biological Psychology|May 30, 2013
White matter microstructure is associated with cognitive control in childrenLaura Chaddock-Heyman, Kirk I Erickson, Michelle W Voss, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2015
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4Zhulun Wang, Daqing Sun, Sheree Johnstone, et al.
Journal of Medicinal Chemistry|February 3, 2006
SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymeraseJay P Powers, Derek E Piper, Yang Li, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitorsYosup Rew, Dustin L McMinn, Zhulun Wang, et al.
Proceedings. Biological Sciences|June 15, 2012
Historical ecology with real numbers: past and present extent and biomass of an imperilled estuarine habitatPhiline S E Zu Ermgassen, Mark D Spalding, Brady Blake, et al.
Bioorganic & Medicinal Chemistry|September 16, 2008
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1Hua Tu, Jay P Powers, Jinsong Liu, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Pageof 26